Marika Heblinski
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels.
Journal: Frontiers in pharmacology
Published: September 19, 2022
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome.
Journal: Journal of cannabis research
Published: September 13, 2021
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.
Journal: British journal of pharmacology
Published: June 18, 2021
Cannabichromene and Δ9-Tetrahydrocannabinolic Acid Identified as Lactate Dehydrogenase-A Inhibitors by in Silico and in Vitro Screening.
Journal: Journal of natural products
Published: April 22, 2021
Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels.
Journal: Cannabis and cannabinoid research
Published: December 30, 2020
Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells.
Journal: British journal of pharmacology
Published: August 22, 2018
Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric Framework.
Journal: Cell metabolism
Published: December 10, 2015
Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT.
Journal: British journal of pharmacology
Published: May 26, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026